Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System: Phase III started

Boston Scientific began the single-blind, international Phase III EVOLVE II trial to compare its Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System vs. its marketed Promus Element Plu...